86exporter.com Home       Products Catalog      Suppliers Catalog      Log In        Sign up
      About Us
      Profile
      Products
      Contact Us

 


BGI Genomics

Company Profile
launched a clinical research program to use Signatera in China for colorectal cancer patients.
The BGI China multicenter program, which launched last week, is the first clinical research application of Natera's Signatera tumor-informed residual disease test in China for use with colorectal cancer patients.


Contact Us
Company: BGI Genomics
Contact: Tommy Ru
Address: beijing
Postcode:
Tel: 17722567742
Fax:
E-mail:          


Copyright© BGI Genomics All Rights Reserved.
Tel : 17722567742 Fax :
Powered by 86exporter.com